Pages that link to "Q37192171"

The following pages link to Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain (Q37192171):

Displaying 35 items.

• HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
• Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04 (Q27675468) (← links)
• Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor (Q27684529) (← links)
• A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1. (Q31132248) (← links)
• HIV-1 and influenza antibodies: seeing antigens in new ways (Q33552488) (← links)
• R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models (Q33640144) (← links)
• Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies (Q33719511) (← links)
• Rational antibody-based HIV-1 vaccine design: current approaches and future directions (Q33937285) (← links)
• Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence (Q34016706) (← links)
• Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained (Q34053295) (← links)
• Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange (Q34055984) (← links)
• Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies (Q34094476) (← links)
• Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site. (Q34133551) (← links)
• Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies (Q34392963) (← links)
• Rapid conformational epitope mapping of anti-gp120 antibodies with a designed mutant panel displayed on yeast (Q34480254) (← links)
• Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo (Q34593860) (← links)
• Conformational and Structural Features of HIV-1 gp120 Underlying the Dual Receptor Antagonism by Cross-Reactive Neutralizing Antibody m18 (Q34934438) (← links)
• Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity (Q35052938) (← links)
• Mammalian production of an isotopically enriched outer domain of the HIV-1 gp120 glycoprotein for NMR spectroscopy. (Q35097577) (← links)
• Progress in the rational design of an AIDS vaccine (Q35137125) (← links)
• Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors (Q35382871) (← links)
• Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. (Q35603504) (← links)
• Eliminating antibody polyreactivity through addition of N-linked glycosylation (Q35684786) (← links)
• An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site (Q37069430) (← links)
• Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. (Q37625296) (← links)
• Stable expression of a foreign protein by a replication-competent rubella viral vector (Q37640717) (← links)
• The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. (Q37667754) (← links)
• Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoprotein (Q37902738) (← links)
• Limitations to the structure‐based design of HIV‐1 vaccine immunogens (Q37910841) (← links)
• Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design (Q38810452) (← links)
• Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model. (Q38879452) (← links)
• Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. (Q42959357) (← links)
• Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category. (Q52569620) (← links)
• The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects. (Q52581587) (← links)
• Vaccine Design Reaches the Atomic Level (Q84553710) (← links)